🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/RT-2026-134Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

ADL-R3 5 mg

RT-2026-134Lot AX-261011-02Analyzed November 17, 2026
ADL-R3 5 mg vial as received

Timeline

Ordered
November 10, 2026
Received
November 16, 2026
Analyzed
November 17, 2026

Sample

Name
ADL-R3 5 mg
Expected
ADL-R3
Amount
1 vial, lyophilized powder

Testing

Client
Axis Research LLC
Test type
Content & purity, fentanyl, pH, enclosure integrity, solubility
Method
HPLC-UV
Content, how much is in it
5.20mg
Label claim: 5 mg
Purity, how clean it is
99.6%
by HPLC-UV peak area

Chromatogram

HPLC-UV

mAU01002000481216202428Retention time (min)18.42
18.42 min, ADL-R3, 99.6%

Additional tests

pH
5.89
Reconstituted sample, calibrated glass electrode
Fentanyl
Not detected
None found above the 20 ng/mL screening cutoff (fentanyl and analogs)
Container closure integrity
~40 kPa
Residual vacuum held, measured before opening
Solubility
100%
Dissolved in water at ~2 mg/mL, clear, no particles

Analyst Comments

White lyophilized powder, clear-cap vial, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 17, 2026

Verification Code

RT-N5WX-4LS1
Verify at purilab.org/verify/RT-N5WX-4LS1

Scan to Verify

RT-N5WX-4LS1

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1